Franco-Leyva T., Torres O.H., Saez Prieto M.E., Boera-Carnicero G., Santos Á., Clotet S., Albert-Jares D., El-Ebiary Y., Agustí-Martí M., Casademont J., Juárez C., Martínez-Martínez L.. Early differentiated CD28(+) CD27(+) T lymphocytes as a biomarker for short and long-term outcomes in older patients with pneumonia. JOURNAL OF LEUKOCYTE BIOLOGY. 2022; 112(5)DOI:10.1002/JLB.5MA0422-370R. PMID:35748037. IF:5.500(Q2/3D).

Romano Cardozo A., Ruiz I., de la Rosa Carrillo D., Peñacoba P.. Tapia's syndrome and pronation in a patient with pneumonia due to COVID-19: About a case. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; 40(9)DOI:10.1016/j.eimc.2021.06.019. PMID:35729048. IF:2.500(Q4/8D).

Alfonsi, C, Stephan-Otto, C, Cortes-Saladelafont, E, Palacios, NJ, Podzamczer-Valls, I, Cruz, NG, Jimenez, MRD, Mico, SI, Vila, MT, Jeltsch, K, Hubschmann, OK, Opladen, T, Fragua, RV, Gomez, T, Fortuny, OA, Jimenez, IG, Laso, EL, Martinez, AR, Lopez, JM, Garcia-Cazorla, A. Volumetric study of brain MRI in a cohort of patients with neurotransmitter disorders. NEURORADIOLOGY. 2022; 64(11)DOI:10.1007/s00234-022-02989-8. PMID:35662359. IF:2.800(Q2/5D).

Martinez-Garcia, MA, Faner, R, Oscullo, G, la Rosa-Carrillo, D, Soler-Cataluna, JJ, Ballester, M, Muriel, A, Agusti, A. Chronic Bronchial Infection Is Associated with More Rapid Lung Function Decline in Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 2022; 19(11)DOI:10.1513/AnnalsATS.202108-974OC. PMID:35666811. IF:8.300(Q1/2D).

Castro, A, Diaz, P, Domingo, P, Garcia-Yubero, C, Losa-Garcia, JE, Castro, A, Vidal-Vilar, N, Aceituno, S. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain. Farmacia Hospitalaria. 2022; 46(6)DOI:10.7399/fh.13038. PMID:36520571. IF:(Q/D).

Domingo, P, Quesada-Lopez, T, Villarroya, J, Cairo, M, Gutierrez, MD, Mateo, MG, Mur, I, Corbacho, N, Domingo, JC, Villarroya, F, Giralt, M. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. LIFE SCIENCES. 2022; 308DOI:10.1016/j.lfs.2022.120948. PMID:36096241. IF:6.100(Q1/2D).

Aparicio, J, Manrique, ACV, Capdevila, J, Boza, FM, Galvan, P, Richart, P, Oliveres, H, Paez, D, Hernando, J, Serrano, S, Vera, R, Hernandez-Yague, X, Gallego, RA, Riesco-Martinez, MC, de Albeniz, XG, Maurel, J. Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01). Clinical & Translational Oncology. 2022; 24(11)DOI:10.1007/s12094-022-02868-x. PMID:35761123. IF:3.400(Q3/6D).

Climent, MA, Font, A, Duran, I, Puente, J, Mendez-Vidal, MJ, Saez, MI, Lobera, CS, Arija, JAA, Gonzalez-Del-Alba, A, Sanchez-Hernandez, A, Fita, MJJ, Esteban, E, Alonso-Gordoa, T, Gonzalez, BM, Maroto, P, Lazaro-Quintela, M, Cassinello-Espinosa, J, Perez-Valderrama, B, Garcias, C, Castellano, D. A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial. EUROPEAN JOURNAL OF CANCER. 2022; 175DOI:10.1016/j.ejca.2022.08.002. PMID:36099670. IF:8.400(Q1/2D).